Covid19 Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Covid19
  • +2 more
  • Breathing and chest mobilization exercises
  • Second phase cardiac rehabilitation
  • Jakarta, Indonesia
    National Cardiovascular Center Harapan Kita Hospital Indonesia
2021-10-12
Oct 12, 2021
T
Recruiting
  • Covid19
  • Vaccine Refusal
  • Community health worker engagement
  • New Orleans, Louisiana
    Tulane University Medical Center
2021-10-12
Oct 12, 2021
L
Not yet recruiting
  • Covid19
  • GSE and Xylitol
  • Control Placebo
  • Miami, Florida
  • +1 more
2021-10-06
Oct 6, 2021
S
Recruiting
  • Covid19
  • Saliva test kit
  • Stanford, California
    Stanford University
2021-10-13
Oct 13, 2021
R
Withdrawn
  • Covid19
  • COVID-19 antibody point of care test kit
  • (no location specified)
2021-10-06
Oct 6, 2021
W
Active, not recruiting
  • Covid19
  • Heterologous stimuli
  • Neutralization assay
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-10-06
Oct 6, 2021
M
Active, not recruiting
  • Covid19
  • Recommended treatment schedule
  • Control treatment schedule
  • Teramo, TE, Italy
  • +1 more
2021-10-05
Oct 5, 2021
C
Completed
  • Covid19
  • COVID-19 test
  • Blood sampling
  • Sherbrooke, Quebec, Canada
    Sherbrooke University
2021-10-12
Oct 12, 2021
W
Recruiting
  • Covid19
  • Questionnaires and Patient Reported Outcomes (PROs)
  • +10 more
  • Saint Louis, Missouri
  • +3 more
2021-10-08
Oct 8, 2021
U
Recruiting
  • SARS-CoV-2 Infection
  • +3 more
    • Seattle, Washington
      University of Washington International Clinical Research Center
    2021-10-08
    Oct 8, 2021
    U
    Not yet recruiting
    • Covid19
    • No intervention.
    • (no location specified)
    2021-10-05
    Oct 5, 2021
    I
    Active, not recruiting
    • Covid19
    • Methylene Blue
    • Saline nasal spray
    • Irkutsk, Irkutskaya Oblast, Russian Federation
      Irkutsk Regional Hospital
    2021-10-11
    Oct 11, 2021
    N
    Active, not recruiting
    • SARS-CoV Infection
    • Covid19
    • ICC Vaccine
    • +2 more
    • Bruce, Australian Capital Territory, Australia
    • +9 more
    2021-10-11
    Oct 11, 2021
    R
    Recruiting
    • Covid19
    • Part A: Upamostat 200 mg
    • +3 more
    • Cutler Bay, Florida
    • +17 more
    2021-10-11
    Oct 11, 2021
    G
    Completed
    • Covid19
      • Ankara, Turkey
        Gazi University Faculty of Medicine, Physical Medicine and Rehab
      2021-10-11
      Oct 11, 2021
      A
      Active, not recruiting
      • Covid19
      • Thorax CT
      • Ankara, Turkey
      • +1 more
      2021-10-11
      Oct 11, 2021
      U
      Recruiting
      • Covid19
      • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
      • Low dose Low molecular weight heparin or Placebo
      • Düsseldorf, Germany
      • +7 more
      2021-10-11
      Oct 11, 2021
      V
      Recruiting
      • Covid19
      • +4 more
      • Cohort study
      • Nashville, Tennessee
        Vanderbilt_University MC
      2021-10-11
      Oct 11, 2021
      U
      Active, not recruiting
      • Covid19
      • +4 more
      • SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
      • Ann Arbor, Michigan
        University of Michigan
      2021-10-11
      Oct 11, 2021
      B
      Not yet recruiting
      • SARS-CoV2 Infection
      • Covid19
      • Low-dose acetylsalicylic acid
      • Placebo
      • (no location specified)
      2021-10-07
      Oct 7, 2021
      P
      Not yet recruiting
      • Covid19
      • SARS-CoV-2 Protein Subunit Recombinant Vaccine
      • SARS-CoV-2 Inactivated Vaccine
      • Jakarta, Greater Jakarta, Indonesia
        Fakultas Kedokteran Universitas Indonesia
      2021-10-04
      Oct 4, 2021